New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A

J Briolat, SD Wu, SK Mahata, B Gonthier… - Cellular and Molecular …, 2005 - Springer
J Briolat, SD Wu, SK Mahata, B Gonthier, D Bagnard, S Chasserot-Golaz, KB Helle, D Aunis…
Cellular and Molecular Life Sciences CMLS, 2005Springer
Catestatin (bCGA 344–364), an endogenous peptide of bovine chromogranin A, was initially
characterized for its effect on the inhibition of catecholamine release from chromaffin cells.
Catestatin and its active domain (bCGA 344–358) were identified in chromaffin cells and in
secretion medium. The present study identified a potent antimicrobial activity of bCGA 344–
358 in the lowmicromolar range against bacteria, fungi and yeasts, without showing any
haemolytic activity. Confocal laser microscopy demonstrated penetration of the …
Abstract
Catestatin (bCGA344–364), an endogenous peptide of bovine chromogranin A, was initially characterized for its effect on the inhibition of catecholamine release from chromaffin cells. Catestatin and its active domain (bCGA344–358) were identified in chromaffin cells and in secretion medium. The present study identified a potent antimicrobial activity of bCGA344–358 in the lowmicromolar range against bacteria, fungi and yeasts, without showing any haemolytic activity. Confocal laser microscopy demonstrated penetration of the rhodaminated peptide into the cell membranes of fungi and yeasts and its intracellular accumulation. Time-lapse videomicroscopy showed arrest of fungal growth upon penetration of the labelled peptide into a fungal filament. We identified several catestatin-containing fragments in the stimulated secretion medium of human polymorphonuclear neutrophils, suggesting the N-terminal sequence of catestatin (bCGA344–358) (named cateslytin) as a novel component of innate immunity.
Springer